Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2023-05-19 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is an announcement of meetings rather than a report or transcript of the meetings. It does not contain financial data, earnings, or detailed presentations. Therefore, it fits the category of an Investor Presentation announcement or update. However, since it is only an intimation of the schedule of meetings and not the presentation itself, it is best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories more specifically.
2023-05-19 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding a newspaper advertisement published about unclaimed equity shares due for transfer to the Investor Education and Protection Fund (IEPF) as per Section 124(6) of the Companies Act, 2013. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The content is an announcement of a newspaper advertisement and does not contain financial statements, management discussion, or detailed financial data. The document length is about 15,000 characters but the content is primarily a notification and request to take the advertisement on record. There is no indication that this is a full report or financial filing. Therefore, this fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-05-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of a conference call discussing the financial results for Q4 and FY23 of Dr. Lal PathLabs. It includes detailed remarks from management, financial highlights, operational updates, and Q&A with analysts. The text explicitly mentions it is a "Transcript of Conference Call on Financial Results for Q4 & FY23" and contains the full text of the call, including speakers and detailed discussion of financial and operational performance. This matches the definition of a Call Transcript (CT). The document length is substantial (15,000 characters), indicating it is the full transcript, not just an announcement or summary. Therefore, the correct classification is CT with high confidence.
2023-05-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges about the schedule of an analyst/institutional investor meeting. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The content is about informing the exchange and public about the timing and nature of an investor meeting, explicitly stating no unpublished price sensitive information will be shared. There are no financial statements, no detailed financial data, no report attachments, or voting results. The document is an announcement of an investor meeting schedule, which fits the category of Investor Presentation (IP) or related investor communication. However, since it is only an intimation of the schedule of the meeting and not the presentation itself, it is best classified as a Regulatory Filing (RNS) because it is a regulatory disclosure about an event rather than the event content or report itself. The document length is short (1843 characters), and it is a formal regulatory announcement. Therefore, the best classification is Regulatory Filings (RNS).
2023-05-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated May 15, 2023, addressed to stock exchanges, informing about the schedule of an analyst/institutional investor meeting via conference call. It explicitly states it is an 'Intimation of Schedule of Analyst/ Institutional Investor Meeting' and contains no financial data or report content. The length is only 1834 characters, indicating it is a brief announcement rather than a full report or transcript. There is no indication of financial results, management discussion, or detailed presentation content. Therefore, this document fits the category of an Investor Presentation (IP) announcement or meeting schedule notice. However, since it is only a schedule intimation and not the presentation itself, it is best classified under Regulatory Filings (RNS) as a general regulatory announcement about investor meetings, per the fallback rule for miscellaneous filings that do not fit other categories.
2023-05-15 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the publication of a newspaper advertisement of the company's financial results for the quarter and financial year ended March 31, 2023. It references compliance with SEBI regulations 30 and 47, which relate to disclosure requirements. The document states that the newspaper advertisement of the financial results has been published and is attached. There is no substantive financial data or detailed financial statements within the text; rather, it is an announcement that the financial results advertisement has been published in newspapers. The document length is 15,000 characters, but the content is primarily an announcement of publication, not the financial report itself. Therefore, according to the "Menu vs Meal" rule, this document should be classified as a Report Publication Announcement (RPA).
2023-05-12 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.